Bioorganic & Medicinal Chemistry 2012-02-15

QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).

Sylvie Mavel, Zoya Mincheva, Nathalie Méheux, Yvan Carcenac, Denis Guilloteau, Mohamed Abarbri, Patrick Emond

Index: Bioorg. Med. Chem. 20 , 1388-95, (2012)

Full Text: HTML

Abstract

The dopamine transporter (DAT) plays a pivotal role in the regulation of dopamine neurotransmission, and is involved in a number of physiological functions and brain disorders. Furthermore the DAT analysis by molecular imaging techniques is a useful tool for the diagnosis and follow up treatment of diseases involving the DAT. In order to predict the affinity of new derivatives for the DAT, different QSAR molecular modeling models based on cocaine were compared. We have evaluated in these models tropane derivatives synthesized with original synthons which coupled properties of both fluorine and iodine atoms. One compound showed a high in vitro affinity and selectivity for the DAT (K(i)=0.87±0.04 nM). This compound should be radiolabeled with radioiodine for further investigations by SPECT.Copyright © 2012 Elsevier Ltd. All rights reserved.


Related Compounds

Related Articles:

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

2011-12-01

[J. Sci. Ind. Res. 65(10) , 808, (2006)]

The ionization mechanisms in direct and dopant-assisted atmospheric pressure photoionization and atmospheric pressure laser ionization.

2014-11-01

[J. Am. Soc. Mass Spectrom. 25(11) , 1870-81, (2014)]

Ion/molecule reactions for detecting ammonia using miniature cylindrical ion trap mass spectrometers.

2011-01-07

[Analyst 136(1) , 120-7, (2011)]

The contribution of bromobenzene to our current understanding of chemically-induced toxicities.

1988-01-01

[Life Sci. 42(13) , 1259-69, (1988)]

Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation.

2011-08-15

[Bioorg. Med. Chem. Lett. 21(16) , 4750-2, (2011)]

More Articles...